
My illustration entitled: “The Observatory of Possible Selves” (Feb 2022) – Inside a mountaintop observatory, an adult looks through a brass telescope that projects several possible versions of their own body onto the dome. The physician stands beside the instrument, explaining what each projection shows. The adult’s hand rests on the dial that can bring any projection into focus or let them all fade.
Genomic Sovereigntism is a normative philosophy of genetic technology concerned with the legitimate allocation, limitation and transfer of authority over interventions that alter human genetic constitution.
“Power to alter a genome is not equivalent to authority over the person whose genome is altered.”
What Is Genomic Sovereigntism?
Genetic technology increasingly gives human beings the capacity not merely to understand biological inheritance, but to intervene in it. Gene therapy, embryo editing, germline modification, genetic enhancement, reproductive genetics, cloning and future synthetic biology therefore raise a question deeper than technological capability:
Who possesses legitimate authority to alter the biological constitution of another human being?
Genomic Sovereigntism begins from the proposition that technological capacity, biological parenthood, professional expertise, political jurisdiction and proprietary ownership do not, by themselves, confer authority over the person who bears the constitutive consequences of genetic intervention.
The Foundational Proposition
Possession of the technological power to alter a human genome does not, by itself, constitute legitimate authority to determine the genetic constitution of the person thereby affected.
This distinction between power and authority forms the philosophical foundation of Genomic Sovereigntism.
Power describes the factual or technological capacity to alter a genome.
Authority describes the legitimate normative standing to decide whether that alteration should occur.
A scientist may possess the technical ability to edit a genome. A physician may possess professional expertise. A parent may possess decision-making responsibilities toward a child. A state may possess regulatory jurisdiction. A corporation may possess intellectual-property rights over a genetic technology. None of these facts alone establishes sovereignty over the person whose biological constitution is altered.
Core Concepts
1. Genomic Power–Authority Distinction
Possessing the technological power to alter a human genome does not, by itself, establish legitimate authority to determine another person’s genetic constitution.
2. Genomic Self-Authorship
Competent persons possess a strong presumptive claim regarding genetic interventions affecting their own biological constitution.
3. Genomic Other-Authorship
Genetic intervention becomes normatively different when one person determines biological characteristics whose enduring consequences are borne by another person.
4. Genomic Authority Gap
A Genomic Authority Gap arises when the actor possessing practical power to determine a genetic intervention is different from the person who bears its constitutive consequences.
5. Sovereignty–Custodianship Distinction
Parents, guardians and other substitute decision-makers may possess constrained authority to act on behalf of another person, but substitute decision-making does not become sovereignty over that person’s biological constitution.
6. Genomic Non-Domination Principle
Genetic technologies should not create avoidable relationships in which one actor acquires arbitrary or structurally disproportionate power over another person’s biological constitution or future.
Genomic Sovereigntism Is Not Genomic Sovereignty
Genomic Sovereigntism should be distinguished from the established concept of genomic sovereignty.
| Genomic Sovereignty | Genomic Sovereigntism | |
|---|---|---|
| Primary concern | Control and governance of genomic information, samples, genetic resources or population-level genomic interests. | Legitimate authority over interventions that alter human genetic constitution. |
| Central question | Who controls genomic information or resources? | Who possesses legitimate authority to alter a human genome? |
| Typical actors | States, populations, communities, institutions and individuals. | Persons, parents, physicians, scientists, regulators, corporations and future generations. |
| Normative focus | Ownership, access, privacy, control and governance. | Authority, consent, custodianship, legitimacy, irreversibility and domination. |
A Taxonomy of Genomic Authority
Genomic Sovereigntism distinguishes between different forms of authority surrounding genetic intervention. These forms of authority are not interchangeable.
| Authority Type | Typical Holder | Nature of Authority |
|---|---|---|
| Sovereign Authority | Competent affected person | Authority concerning interventions upon one’s own biological constitution. |
| Custodial Authority | Parent or guardian | Limited authority exercised on behalf of another person who cannot presently decide. |
| Professional Authority | Physician, researcher or scientist | Authority concerning competence, procedure, evidence and safety, but not sovereignty over the person. |
| Regulatory Authority | State or regulator | Authority to establish lawful boundaries, safeguards and permissible practices. |
| Proprietary Claims | Inventor or technology owner | Rights over technologies and intellectual property, but not authority over persons altered through those technologies. |
| Prospective or Latent Claims | Future affected person | Moral claims that constrain decisions made before the person is capable of exercising agency. |
The Genomic Authority Gradient
The justificatory burden for genetic intervention rises as the distance between the decision-maker and affected person increases, and as the intervention becomes more constitutive, irreversible and heritable.
Agency Distance
How far is the decision-maker from the person who bears the biological consequences?
Constitutive Depth
How extensively does the intervention shape enduring characteristics of the resulting person?
Irreversibility
How realistically can the affected person later reject, reverse or escape the intervention?
Heritable Reach
Does the intervention affect only one individual, or does it extend biologically into future generations?
The Genomic Sovereigntism Canon
Genomic Sovereigntism develops across 17 essays from 2010 to 2026, progressing from the distinction between technological power and legitimate authority toward a mature theory of genetic intervention, custodianship, non-domination and intergenerational authority.
28 May 2010
Genomic Sovereigntism: Power, Authority and the Human Genome
The founding article introducing the principle that genetic capability creates power, but power alone does not establish legitimate authority over persons.
18 August 2011
The Genome Is Not the Person: Against Genetic Essentialism
Rejects the reduction of human identity, dignity and moral status to genetic constitution.
20 August 2012
Power Is Not Authority: The Ethics of Altering Another Human Genome
Formally introduces the Genomic Power–Authority Distinction.
20 December 2013
Genomic Self-Authorship: The Right to Alter One’s Own Biology
Develops the principle of self-directed authority over genetic interventions affecting one’s own biology.
10 February 2014
Beyond Therapy and Enhancement: Who Has Authority to Decide?
Argues that therapy versus enhancement cannot replace the deeper question of who possesses legitimate authority.
18 September 2015
Genomic Other-Authorship: When One Person Designs Another
Introduces the distinction between self-directed genetic intervention and interventions whose consequences are borne by another person.
18 September 2016
The Genomic Authority Gap: When Power and Permission Belong to Different People
Identifies the structural separation between possession of genetic power and legitimate authorization.
20 May 2017
Custodians, Not Sovereigns: Parental Authority Over the Future Genome
Develops the Sovereignty–Custodianship Distinction and limits parental authority over genetic intervention.
17 December 2018
The Irreversible Genome: Consent, Germline Editing and Future Agency
Examines how irreversible genetic intervention increases the justificatory burden placed upon those making decisions for others.
20 July 2019
Whose Genome Is It to Change? Competing Claims Over Genetic Intervention
Examines competing claims involving patients, parents, clinicians, scientists, regulators and future descendants.
20 July 2020
Genomic Authority Is Not Genomic Ownership
Separates authority over genetic intervention from genomic ownership, privacy, data governance and genomic sovereignty.
20 October 2021
The Heritable Decision: What One Generation May Decide for Another
Develops the problem of intergenerational authority where genetic consequences extend beyond the initial individual.
18 June 2022
No Patent Over the Person: Proprietary Power and Genetic Intervention
Distinguishes ownership of genetic technologies from authority over persons altered through those technologies.
20 October 2023
The Genomic Non-Domination Principle: When Biological Power Becomes Rule
Develops the principle that genomic power should not become arbitrary or structurally coercive domination over persons.
8 July 2024
Formalizes distinct categories of authority and establishes that these forms of authority cannot simply substitute for one another.
13 March 2025
The Genomic Authority Gradient: Agency, Irreversibility and Heritable Reach
Introduces the evaluative framework of agency distance, constitutive depth, irreversibility and heritable reach.
16 November 2026
Genomic Sovereigntism: A Theory of Authority Over Human Genetic Modification
The definitive synthesis consolidating the mature philosophy, its principles, authority taxonomy, evaluative framework and research agenda.
Domains of Application
Somatic Gene Editing
Genetic intervention affecting an existing individual, including therapeutic and enhancement applications.
Embryo Editing
Intervention where the person bearing the constitutive consequences cannot participate in the decision.
Germline Modification
Genetic changes whose biological consequences may extend into subsequent generations.
Genetic Enhancement
Questions concerning self-directed enhancement versus the intentional genetic design of another person.
Cloning
Questions concerning personhood, genetic identity, biological authorship and the independence of genetically replicated persons.
Synthetic Human Biology
Future interventions involving synthetic genomes, artificial chromosomes and increasingly engineered human biological systems.
The Question Behind the Technology
Genetic technology may eventually allow humanity to alter disease susceptibility, physiology, cognition, appearance, longevity and biological inheritance. Yet increasing humanity’s collective technological control over evolution does not necessarily increase the sovereignty of the individual people whose lives are shaped by those decisions.
The central question of Genomic Sovereigntism is not merely what humanity can change, but who has legitimate authority to decide what is changed, for whom, and with what limits.

My illustration “The Observatory of Possible Selves” (Feb 2022) work-in-progress. The art represents that genetic technology can reveal many possible selves, while the choice of who to become belongs to the person who will live with it.
Previous ART for this hub

My illustration entitled: “The Chisel at Rest” (June 2010) – In a cavernous sculpture studio, a sculptor pauses with a raised mallet beside a half-carved marble giant. The living person who posed for it steps forward to guide the sculptor’s hand, their fingers meeting at the chisel just before the next strike.
